On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini. This instrumentation change is necessary as Bio-Rad is discontinuing service on our existing QuickStep instrumentation.
Although the Immucor assay and sample requirements will remain the same, the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list will be available on the CTS website on 04/29/19.
The new online Learning Center with new content can still be found under the “Training” folder on ...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...